Zenobe Gramme Cert (XBRU:ZEN) Research & Development: €0.00 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBRU:ZEN Zenobe Gramme Cert XBRU:ZEN
60 GF Score
Price €218.00
GF Value €219.45
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Zenobe Gramme Cert Research & Development?

Zenobe Gramme Cert XBRU:ZEN 60 Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus rates XBRU:ZEN with a GF Score™ of 60/100 and a GF Value™ of €219.45 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Zenobe Gramme Cert's Research & Development for the six months ended in Jun. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00 Mil.

Zenobe Gramme Cert  (XBRU:ZEN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zenobe Gramme Cert Research & Development Related Terms

Zenobe Gramme Cert Research & Development Historical Data

* Premium members only.

The historical data trend for Zenobe Gramme Cert's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenobe Gramme Cert Research & Development Chart

Zenobe Gramme Cert Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zenobe Gramme Cert Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XBRU:ZEN
60GF Score
Zenobe Gramme Cert XBRU:ZEN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenobe Gramme Cert Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Zenobe Gramme Cert (XBRU:ZEN) has a Research & Development of €0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Zenobe Gramme Cert and its competitors.
Is Zenobe Gramme Cert's Research & Development too high?
Zenobe Gramme Cert's current Research & Development is €0.00 Mil. Overall, Zenobe Gramme Cert has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zenobe Gramme Cert's Research & Development compare to CBRE and BEKE?
Zenobe Gramme Cert's Research & Development of €0.00 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Zenobe Gramme Cert and its competitors. Zenobe Gramme Cert's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenobe Gramme Cert stock overvalued right now?
Based on GuruFocus' analysis, Zenobe Gramme Cert (XBRU:ZEN) is currently considered Fairly Valued. The stock's GF Value™ is €219.45, compared to a current price of €218.00 — trading 0.7% below its estimated fair value. The current Research & Development is €0.00 Mil. Zenobe Gramme Cert's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Zenobe Gramme Cert (XBRU:ZEN), the current Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenobe Gramme Cert (XBRU:ZEN) Overvalued in 2026?

Based on GuruFocus' analysis, Zenobe Gramme Cert stock appears to be undervalued. The current stock price of €218.00 is trading 0.7% below its estimated GF Value™ of €219.45. GuruFocus considers Zenobe Gramme Cert to be Fairly Valued.

Key valuation signals for XBRU:ZEN:

  • Research & Development: €0.00 Mil
  • GF Value™: €219.45 vs. price of €218.00 (0.7% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the XBRU:ZEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenobe Gramme Cert Business Description

Address Magali Istas, Petercam sa, Place Sainte Gudule 19, Brussels, BEL, 1000
Zenobe Gramme Cert provides real estate services. It offers certificates to finance a building.
60GF Score

Get the complete analysis for XBRU:ZEN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€218.00
Price
€219.45
GF Value